Long-time heterozygous carriers of pathogenic CFTR variants were not at increased risk of developing CF or CFTR-related diseases; however, the impact of heterozygous carriage of clinically significant genetic CFTR variants in the development of various types of pathology is no longer as harmless as previously thought. Here, CFTR is linked to cystic fibrosis.